O	0	3	The	The	DT	B-NP
O	4	13	threshold	threshold	NN	I-NP
O	14	19	level	level	NN	I-NP
O	20	22	of	of	IN	B-PP
O	23	34	adenomatous	adenomatous	JJ	B-NP
O	35	44	polyposis	polyposis	NN	I-NP
O	45	49	coli	coli	NN	I-NP
O	50	57	protein	protein	NN	I-NP
O	58	61	for	for	IN	B-PP
O	62	67	mouse	mouse	NN	B-NP
B-Multi-tissue_structure	68	78	intestinal	intestinal	JJ	I-NP
O	79	92	tumorigenesis	tumorigenesis	NN	I-NP
O	92	93	.	.	.	O

O	95	98	The	The	DT	B-NP
O	99	110	adenomatous	adenomatous	JJ	I-NP
O	111	120	polyposis	polyposis	NN	I-NP
O	121	125	coli	coli	NN	I-NP
O	126	127	(	(	(	O
O	127	130	APC	APC	NN	B-NP
O	130	131	)	)	)	O
O	132	136	gene	gene	NN	B-NP
O	136	137	,	,	,	O
O	138	143	whose	whose	WP$	B-NP
O	144	153	mutations	mutation	NNS	I-NP
O	154	157	are	be	VBP	B-VP
O	158	169	responsible	responsible	JJ	B-ADJP
O	170	173	for	for	IN	B-PP
O	174	182	familial	familial	JJ	B-NP
O	183	194	adenomatous	adenomatous	JJ	I-NP
O	195	204	polyposis	polyposis	NN	I-NP
O	204	205	,	,	,	O
O	206	208	is	be	VBZ	B-VP
O	209	210	a	a	DT	B-NP
O	211	216	major	major	JJ	I-NP
O	217	225	negative	negative	JJ	I-NP
O	226	236	controller	controller	NN	I-NP
O	237	239	of	of	IN	B-PP
O	240	243	the	the	DT	B-NP
O	244	247	Wnt	Wnt	NN	I-NP
O	247	248	/	/	SYM	O
O	248	252	beta	beta	SYM	O
O	252	253	-	-	HYPH	O
O	253	260	catenin	catenin	NN	B-NP
O	261	268	pathway	pathway	NN	I-NP
O	268	269	.	.	.	O

O	270	272	To	To	TO	B-VP
O	273	284	investigate	investigate	VB	I-VP
O	285	288	the	the	DT	B-NP
O	289	293	dose	dose	NN	I-NP
O	293	294	-	-	HYPH	B-NP
O	294	303	dependent	dependent	JJ	I-NP
O	304	311	effects	effect	NNS	I-NP
O	312	314	of	of	IN	B-PP
O	315	318	APC	APC	NN	B-NP
O	319	326	protein	protein	NN	I-NP
O	327	329	in	in	IN	B-PP
O	330	341	suppressing	suppress	VBG	B-VP
B-Multi-tissue_structure	342	352	intestinal	intestinal	JJ	B-NP
O	353	366	tumorigenesis	tumorigenesis	NN	I-NP
O	366	367	,	,	,	O
O	368	370	we	we	PRP	B-NP
O	371	382	constructed	construct	VBD	B-VP
O	383	389	mutant	mutant	JJ	B-NP
O	390	394	mice	mouse	NNS	I-NP
O	395	403	carrying	carry	VBG	B-VP
O	404	415	hypomorphic	hypomorphic	JJ	B-NP
O	416	419	Apc	Apc	NN	I-NP
O	420	427	alleles	allele	NNS	I-NP
O	428	431	Apc	Apc	NN	I-NP
O	431	432	(	(	(	O
O	432	436	neoR	neoR	NN	B-NP
O	436	437	)	)	)	O
O	438	441	and	and	CC	O
O	442	445	Apc	Apc	NN	B-NP
O	445	446	(	(	(	O
O	446	450	neoF	neoF	NN	B-NP
O	450	451	)	)	)	O
O	452	457	whose	whose	WP$	B-NP
O	458	468	expression	expression	NN	I-NP
O	469	475	levels	level	NNS	I-NP
O	476	480	were	be	VBD	B-VP
O	481	488	reduced	reduce	VBN	I-VP
O	489	491	to	to	TO	B-PP
O	492	494	20	20	CD	B-NP
O	494	495	%	%	NN	I-NP
O	496	499	and	and	CC	O
O	500	502	10	10	CD	B-NP
O	502	503	%	%	NN	I-NP
O	504	506	of	of	IN	B-PP
O	507	510	the	the	DT	B-NP
O	511	515	wild	wild	JJ	I-NP
O	516	520	type	type	NN	I-NP
O	520	521	,	,	,	O
O	522	534	respectively	respectively	RB	B-ADVP
O	534	535	.	.	.	O

O	536	544	Although	Although	IN	B-SBAR
O	545	549	both	both	DT	B-NP
O	550	561	hypomorphic	hypomorphic	JJ	I-NP
O	562	575	heterozygotes	heterozygote	NNS	I-NP
O	576	585	developed	develop	VBD	B-VP
B-Pathological_formation	586	596	intestinal	intestinal	JJ	B-NP
I-Pathological_formation	597	603	polyps	polyp	NNS	I-NP
O	603	604	,	,	,	O
B-Cancer	605	610	tumor	tumor	NN	B-NP
O	611	625	multiplicities	multiplicity	NNS	I-NP
O	626	630	were	be	VBD	B-VP
O	631	635	much	much	RB	B-ADJP
O	636	641	lower	low	JJR	I-ADJP
O	642	646	than	than	IN	B-PP
O	647	651	that	that	DT	B-NP
O	652	654	in	in	IN	B-PP
O	655	658	Apc	Apc	NN	B-NP
O	658	659	(	(	(	O
O	659	667	Delta716	Delta716	NN	B-NP
O	667	668	)	)	)	O
O	669	673	mice	mouse	NNS	B-NP
O	673	674	,	,	,	O
O	675	688	heterozygotes	heterozygote	NNS	B-NP
O	689	691	of	of	IN	B-PP
O	692	694	an	an	DT	B-NP
O	695	698	Apc	Apc	NN	I-NP
O	699	703	null	null	JJ	I-NP
O	704	710	allele	allele	NN	I-NP
O	710	711	.	.	.	O

O	712	716	Like	Like	IN	B-PP
O	717	719	in	in	IN	B-PP
O	720	723	Apc	Apc	NN	B-NP
O	723	724	(	(	(	O
O	724	732	Delta716	Delta716	NN	B-NP
O	732	733	)	)	)	O
O	734	738	mice	mouse	NNS	B-NP
O	738	739	,	,	,	O
O	740	744	loss	loss	NN	B-NP
O	745	747	of	of	IN	B-PP
O	748	751	the	the	DT	B-NP
O	752	756	wild	wild	JJ	I-NP
O	756	757	-	-	HYPH	I-NP
O	757	761	type	type	NN	I-NP
O	762	765	Apc	Apc	NN	I-NP
O	766	772	allele	allele	NN	I-NP
O	773	776	was	be	VBD	B-VP
O	777	786	confirmed	confirm	VBN	I-VP
O	787	790	for	for	IN	B-PP
O	791	794	all	all	DT	B-NP
B-Pathological_formation	795	801	polyps	polyp	NNS	I-NP
O	802	810	examined	examine	VBN	B-VP
O	811	813	in	in	IN	B-PP
O	814	817	the	the	DT	B-NP
O	818	821	Apc	Apc	NN	I-NP
O	821	822	(	(	(	O
O	822	826	neoR	neoR	NN	B-NP
O	826	827	)	)	)	O
O	828	831	and	and	CC	O
O	832	835	Apc	Apc	NN	B-NP
O	835	836	(	(	(	O
O	836	840	neoF	neoF	NN	B-NP
O	840	841	)	)	)	O
O	842	846	mice	mouse	NNS	B-NP
O	846	847	.	.	.	O

O	848	850	In	In	IN	B-PP
O	851	854	the	the	DT	B-NP
B-Cell	855	864	embryonic	embryonic	JJ	I-NP
I-Cell	865	869	stem	stem	NN	I-NP
I-Cell	870	875	cells	cell	NNS	I-NP
O	876	886	homozygous	homozygous	JJ	B-ADJP
O	887	890	for	for	IN	B-PP
O	891	896	these	these	DT	B-NP
O	897	908	hypomorphic	hypomorphic	JJ	I-NP
O	909	912	Apc	Apc	NN	I-NP
O	913	920	alleles	allele	NNS	I-NP
O	920	921	,	,	,	O
O	922	925	the	the	DT	B-NP
O	926	931	level	level	NN	I-NP
O	932	934	of	of	IN	B-PP
O	935	938	the	the	DT	B-NP
O	939	942	APC	APC	NN	I-NP
O	943	950	protein	protein	NN	I-NP
O	951	954	was	be	VBD	B-VP
O	955	964	inversely	inversely	RB	I-VP
O	965	975	correlated	correlate	VBN	I-VP
O	976	980	with	with	IN	B-PP
O	981	985	both	both	CC	O
O	986	989	the	the	DT	B-NP
O	990	994	beta	beta	SYM	I-NP
O	994	995	-	-	HYPH	I-NP
O	995	1002	catenin	catenin	NN	I-NP
O	1003	1015	accumulation	accumulation	NN	I-NP
O	1016	1019	and	and	CC	O
O	1020	1024	beta	beta	SYM	B-NP
O	1024	1025	-	-	HYPH	I-NP
O	1025	1032	catenin	catenin	NN	I-NP
O	1032	1033	/	/	SYM	I-NP
O	1033	1034	T	T	NN	I-NP
O	1034	1035	-	-	HYPH	B-NP
O	1035	1039	cell	cell	NN	I-NP
O	1040	1046	factor	factor	NN	I-NP
O	1047	1062	transcriptional	transcriptional	JJ	I-NP
O	1063	1071	activity	activity	NN	I-NP
O	1071	1072	.	.	.	O

O	1073	1078	These	These	DT	B-NP
O	1079	1086	results	result	NNS	I-NP
O	1087	1094	suggest	suggest	VBP	B-VP
O	1095	1099	that	that	IN	B-SBAR
O	1100	1103	the	the	DT	B-NP
O	1104	1111	reduced	reduce	VBN	I-NP
O	1112	1115	APC	APC	NN	I-NP
O	1116	1123	protein	protein	NN	I-NP
O	1124	1129	level	level	NN	I-NP
O	1130	1139	increases	increase	VBZ	B-VP
B-Pathological_formation	1140	1150	intestinal	intestinal	JJ	B-NP
I-Pathological_formation	1151	1156	polyp	polyp	NN	I-NP
O	1157	1169	multiplicity	multiplicity	NN	I-NP
O	1170	1177	through	through	IN	B-PP
O	1178	1190	quantitative	quantitative	JJ	B-NP
O	1191	1202	stimulation	stimulation	NN	I-NP
O	1203	1205	of	of	IN	B-PP
O	1206	1209	the	the	DT	B-NP
O	1210	1214	beta	beta	SYM	I-NP
O	1214	1215	-	-	HYPH	I-NP
O	1215	1222	catenin	catenin	NN	I-NP
O	1222	1223	/	/	SYM	I-NP
O	1223	1224	T	T	NN	I-NP
O	1224	1225	-	-	HYPH	B-NP
O	1225	1229	cell	cell	NN	I-NP
O	1230	1236	factor	factor	NN	I-NP
O	1237	1250	transcription	transcription	NN	I-NP
O	1250	1251	.	.	.	O

O	1252	1254	We	We	PRP	B-NP
O	1255	1262	further	further	RB	B-ADVP
O	1263	1272	estimated	estimate	VBD	B-VP
O	1273	1276	the	the	DT	B-NP
O	1277	1286	threshold	threshold	NN	I-NP
O	1287	1289	of	of	IN	B-PP
O	1290	1293	APC	APC	NN	B-NP
O	1294	1301	protein	protein	NN	I-NP
O	1302	1307	level	level	NN	I-NP
O	1308	1312	that	that	WDT	B-NP
O	1313	1318	forms	form	VBZ	B-VP
O	1319	1322	one	one	CD	B-NP
B-Pathological_formation	1323	1328	polyp	polyp	NN	I-NP
O	1329	1332	per	per	IN	B-PP
O	1333	1338	mouse	mouse	NN	B-NP
O	1339	1341	as	as	RB	B-PP
O	1342	1355	approximately	approximately	RB	B-NP
O	1356	1358	15	15	CD	I-NP
O	1358	1359	%	%	NN	I-NP
O	1360	1362	of	of	IN	B-PP
O	1363	1366	the	the	DT	B-NP
O	1367	1371	wild	wild	JJ	I-NP
O	1372	1376	type	type	NN	I-NP
O	1376	1377	.	.	.	O

O	1378	1383	These	These	DT	B-NP
O	1384	1391	results	result	NNS	I-NP
O	1392	1396	also	also	RB	B-ADVP
O	1397	1404	suggest	suggest	VBP	B-VP
O	1405	1416	therapeutic	therapeutic	JJ	B-NP
O	1417	1429	implications	implication	NNS	I-NP
O	1430	1440	concerning	concern	VBG	B-VP
O	1441	1444	Wnt	Wnt	NN	B-NP
O	1445	1454	signaling	signaling	NN	I-NP
O	1455	1465	inhibitors	inhibitor	NNS	I-NP
O	1465	1466	.	.	.	O

